Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Post by SeniorCon Sep 10, 2021 12:22pm
309 Views
Post# 33840130

DM valuation

DM valuation

problem is the uncertainty of COVID testing and the lack of AI numbers. When the AI needle will move we will be easily at 25x times the AI revenus like the AI industry.  I believe in a strong 25x because of the huge positive cash-flow supported by the COVID.  So to my point COVID add no or little value but is the insurance for stability.  If the AI revenus can seriously be anticipated at 17M$/y for 2-3 years ahead we will hit the 1$ with solid foundations and position for upgrading the listing.  If COVID testing starts to be seen as a recurring long run revenue source (still not the case) then we may think it will contribute at 10X revenues as this is not IT.   In the meantime we can be anywhere depending on how people see COVID testing.  

So gogogo for a well synchronized cascade of AI announcement we are lower and better positioned than any organization.  DYODD

<< Previous
Bullboard Posts
Next >>